BRPI0611289A2 - uso de ácido adamatil metoxidifenil propenóico para o tratamento de acne - Google Patents

uso de ácido adamatil metoxidifenil propenóico para o tratamento de acne Download PDF

Info

Publication number
BRPI0611289A2
BRPI0611289A2 BRPI0611289-7A BRPI0611289A BRPI0611289A2 BR PI0611289 A2 BRPI0611289 A2 BR PI0611289A2 BR PI0611289 A BRPI0611289 A BR PI0611289A BR PI0611289 A2 BRPI0611289 A2 BR PI0611289A2
Authority
BR
Brazil
Prior art keywords
acne
treatment
mice
skin
gel
Prior art date
Application number
BRPI0611289-7A
Other languages
English (en)
Portuguese (pt)
Inventor
Claudio Pisano
Loredana Vesci
Original Assignee
Sigma Tau Ind Farma Riunite Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farma Riunite Spa filed Critical Sigma Tau Ind Farma Riunite Spa
Publication of BRPI0611289A2 publication Critical patent/BRPI0611289A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
BRPI0611289-7A 2005-05-20 2006-05-05 uso de ácido adamatil metoxidifenil propenóico para o tratamento de acne BRPI0611289A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000248A ITRM20050248A1 (it) 2005-05-20 2005-05-20 Uso acido adamantil metossidifenil propenoico per il trattamento di patologie cutanee.
ITRM2005A000248 2005-05-20
PCT/EP2006/062088 WO2006122883A1 (en) 2005-05-20 2006-05-05 Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne

Publications (1)

Publication Number Publication Date
BRPI0611289A2 true BRPI0611289A2 (pt) 2010-08-31

Family

ID=36646157

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0611289-7A BRPI0611289A2 (pt) 2005-05-20 2006-05-05 uso de ácido adamatil metoxidifenil propenóico para o tratamento de acne

Country Status (13)

Country Link
US (1) US7635719B2 (enExample)
EP (1) EP1890671B1 (enExample)
JP (1) JP5072833B2 (enExample)
KR (1) KR101307910B1 (enExample)
CN (1) CN101180028B (enExample)
AR (1) AR054361A1 (enExample)
AU (1) AU2006248981B2 (enExample)
BR (1) BRPI0611289A2 (enExample)
CA (1) CA2606567A1 (enExample)
IT (1) ITRM20050248A1 (enExample)
MX (1) MX2007014222A (enExample)
TW (1) TWI365753B (enExample)
WO (1) WO2006122883A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5109383B2 (ja) * 2007-01-31 2012-12-26 大正製薬株式会社 アダパレン含有外用剤組成物
JP2009137874A (ja) * 2007-12-05 2009-06-25 Authele:Kk ビタミンＣ（Ａｓｃｏｒｂｉｃａｃｉｄ）を含有するレシチンゲルおよびその製造方法
TW201031402A (en) * 2008-12-24 2010-09-01 Sigma Tau Ind Farmaceuti New retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties
EP3301085A1 (en) * 2016-09-29 2018-04-04 Biogem S.Ca.R.L. Retinoid derivatives with antitumor activity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6071923A (en) * 1994-09-16 2000-06-06 Bar-Ilan University Retinoyloxy aryl-substituted alkylene butyrates useful for the treatment of cancer and other proliferative diseases
FR2752734B1 (fr) * 1996-09-02 1998-11-06 Cird Galderma Utilisation de retinoides pour la preparation d'un medicament destine a traiter les affections liees a une surexpression de vegf
US5994330A (en) * 1998-11-09 1999-11-30 El Khoury; Georges F. Topical application of muscarinic agents such as neostigmine for treatment of acne and other inflammatory conditions
ITRM20010464A1 (it) * 2001-07-31 2003-01-31 Sigma Tau Ind Farmaceuti Derivati retinoidi ad attivita' antiangiogenica, antitumorale e pro-apoptotica.
WO2003075908A1 (en) * 2002-03-12 2003-09-18 Galderma Research & Development, S.N.C. Use of adapalene for the treatment of dermatological disorders

Also Published As

Publication number Publication date
AU2006248981A1 (en) 2006-11-23
WO2006122883A1 (en) 2006-11-23
TW200716192A (en) 2007-05-01
KR20080016573A (ko) 2008-02-21
US20080153916A1 (en) 2008-06-26
MX2007014222A (es) 2008-02-07
CN101180028A (zh) 2008-05-14
US7635719B2 (en) 2009-12-22
WO2006122883A9 (en) 2012-10-04
ITRM20050248A1 (it) 2006-11-21
HK1117737A1 (en) 2009-01-23
EP1890671A1 (en) 2008-02-27
KR101307910B1 (ko) 2013-09-16
CN101180028B (zh) 2010-12-08
AR054361A1 (es) 2007-06-20
JP2008540603A (ja) 2008-11-20
AU2006248981B2 (en) 2011-06-02
CA2606567A1 (en) 2006-11-23
JP5072833B2 (ja) 2012-11-14
EP1890671B1 (en) 2014-03-05
TWI365753B (en) 2012-06-11

Similar Documents

Publication Publication Date Title
JP6818792B2 (ja) メラニン改変組成物および使用方法
Yokota et al. Influence of nanoparticle size on the skin penetration, skin retention and anti-inflammatory activity of non-steroidal anti-inflammatory drugs
US7067556B2 (en) Compositions containing antimicrobials and urea for the treatment of dermatological disorders and methods for their use
JP3827195B2 (ja) 消炎鎮痛剤
CN102548564A (zh) 用于预防和治疗痤疮的包含作为活性成分的蜂毒的组合物
HK1223297A1 (en) Topical retinoid solutions
BRPI0611289A2 (pt) uso de ácido adamatil metoxidifenil propenóico para o tratamento de acne
RU2450836C1 (ru) Комбинированная мазевая композиция для уменьшения интенсивности локальной гиперпигментации кожи
US20150119427A1 (en) Waterborne topical compositions for the delivery of azelaic acid for treatment of skin conditions such as acne vulgaris, rosacea, seborrheic dermatitis
HK1117737B (en) Use of adamantyl methoxydi phenyl propenoic acid for the treatment of acne
Salim Emerging Formulations and Clinical Applications of Topical Salicylic Acid in Acne management
Zhang et al. Topical delivery of Lidocaine using spicules for local anesthesia
US10022348B2 (en) Topical solution of isotretinoin
Virlan et al. Evaluation of topical remedies in the treatment of acne available in the Republic of Moldova
Kim et al. Retinyl retinoate, a retinoid derivative improves acne vulgaris in double-blind, vehicle-controlled clinical study
Farah The effect of heat and chemical penetration enhancers on the follicular absorption of topically applied drugs
Patel Formulation Development and Evaluation of Bioadhesive Drug Delivery System Containing Selected Phytopharmaceuticals
WO2022189945A1 (en) Topical cannabinoid compositions and methods for treating skin diseases
Naudé Formulation, in vitro release and transdermal diffusion of Vitamin A and Zinc for the treatment of acne
WO2021189077A1 (en) Methods for treating acne
Abdalla et al. Outcome of Adapalene and Isotretinoin in the Treatment of Acne Vulgaris
Parab et al. DESIGN OF TRAMADOL HYDROCHLORIDE LOADED SOLID LIPID NANOPARTICLES BASED GELS FOR PAIN MANAGEMENT
Samuels Managing patient expectations in acne treatment
White et al. Pharmacology of salicylic acid (SA) in acne vulgaris Otto Mills, PhD, Robert Wood Johnson Medical School, New Brunswick, NJ, United States; Donald Adler, DO, private practice, Doylestown, PA, United States; Robert Verdicchio, PhD, Verdi Enterprise, Succasunna, NJ The role of SA is acne treatment is dependent upon several pharmacological actions
BR112019017045A2 (pt) composições para tratar acne

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2308 DE 31/03/2015.